News Breaks |
|
|
| January 16, 2013 |
| 06:51 EDT |  | SNCR | Synchronoss upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse upgraded Synchronoss based on solid business momentum from AT&T smartphone unit sales, R&D tax credit extension, and the potential next iPhone launch in Q2. Price target raised to $29 from $20. |
|
|
News For SNCR From The Last 14 Days Check below for free stories on SNCR the last two weeks. |
|
|
| May 10, 2013 |
| 10:00 EDT |  | SNCR | On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3D Systems (DDD) initiated with a Buy at Janney Capital... Actavis (ACT) initiated with an Outperform at BMO Capital... Allergan (AGN) initiated with an Outperform at BMO Capital... Emeritus (ESC) initiated with an Outperform at Wells Fargo... Ensign Group (ENSG) initiated with a Market Perform at Wells Fargo... Forest Labs (FRX) initiated with an Underperform at BMO Capital... J2 Global (JCOM) initiated with an Outperform at Wedbush... Mylan (MYL) initiated with an Underperform at BMO Capital... Splunk (SPLK) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with an Outperform at BMO Capital... Workday (WDAY) initiated with an Outperform at Oppenheimer... Nuance (NUAN) initiated with an Outperform at Wedbush... Demandware (DWRE) initiated with an Outperform at Wedbush... Synchronoss (SNCR) initiated with an Outperform at Wedbush... Trius Therapeutics (TSRX) initiated with a Buy at Guggenheim... Proto Labs (PRLB) initiated with a Buy at Janney Capital... Stratasys (SSYS) initiated with a Buy at Janney Capital. |
|
| 07:26 EDT | | SNCR | Synchronoss initiated with an Outperform at Wedbush
 Subscribe for More Information |
|
|
|
|
|
